Phase 1b Study of Brexucabtagene Autoleucel Plus Dasatinib in Adults With Acute Lymphoblastic Leukemia
Latest Information Update: 13 May 2025
At a glance
- Drugs Brexucabtagene autoleucel (Primary) ; Dasatinib (Primary)
- Indications Precursor B-cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
Most Recent Events
- 06 Oct 2023 Status changed from not yet recruiting to recruiting.
- 18 Aug 2023 New trial record